Aurinia Announces Japan Approval of LUPKYNIS (Voclosporin) to Treat Lupus Nephritis (Businesswire) - Sep 24, 2024 - "Aurinia Pharmaceuticals Inc...announced that the Japanese Ministry of Health, Labour, and Welfare has approved voclosporin, a second-generation calcineurin inhibitor, in combination with mycophenolate mofetil (MMF) to treat lupus nephritis (LN)....The approval is based on data from the AURORA Clinical Program..."
Japan approval • Immunology • Lupus • Lupus Nephritis
|